1. Home
  2. BHM vs IXHL Comparison

BHM vs IXHL Comparison

Compare BHM & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHM
  • IXHL
  • Stock Information
  • Founded
  • BHM 2022
  • IXHL 2001
  • Country
  • BHM United States
  • IXHL Australia
  • Employees
  • BHM N/A
  • IXHL N/A
  • Industry
  • BHM Real Estate Investment Trusts
  • IXHL
  • Sector
  • BHM Real Estate
  • IXHL
  • Exchange
  • BHM Nasdaq
  • IXHL Nasdaq
  • Market Cap
  • BHM 51.9M
  • IXHL 49.1M
  • IPO Year
  • BHM N/A
  • IXHL N/A
  • Fundamental
  • Price
  • BHM $11.98
  • IXHL $0.45
  • Analyst Decision
  • BHM Strong Buy
  • IXHL
  • Analyst Count
  • BHM 1
  • IXHL 0
  • Target Price
  • BHM $15.00
  • IXHL N/A
  • AVG Volume (30 Days)
  • BHM 3.3K
  • IXHL 36.4M
  • Earning Date
  • BHM 01-01-0001
  • IXHL 11-13-2025
  • Dividend Yield
  • BHM 4.38%
  • IXHL N/A
  • EPS Growth
  • BHM N/A
  • IXHL N/A
  • EPS
  • BHM N/A
  • IXHL N/A
  • Revenue
  • BHM $71,496,000.00
  • IXHL $86,000.00
  • Revenue This Year
  • BHM N/A
  • IXHL $1,188.37
  • Revenue Next Year
  • BHM N/A
  • IXHL N/A
  • P/E Ratio
  • BHM N/A
  • IXHL N/A
  • Revenue Growth
  • BHM 27.87
  • IXHL 616.67
  • 52 Week Low
  • BHM $9.30
  • IXHL $0.08
  • 52 Week High
  • BHM $16.37
  • IXHL $3.12
  • Technical
  • Relative Strength Index (RSI)
  • BHM 38.16
  • IXHL 42.48
  • Support Level
  • BHM $11.65
  • IXHL $0.43
  • Resistance Level
  • BHM $11.97
  • IXHL $0.50
  • Average True Range (ATR)
  • BHM 0.34
  • IXHL 0.07
  • MACD
  • BHM 0.04
  • IXHL -0.01
  • Stochastic Oscillator
  • BHM 42.35
  • IXHL 16.20

About BHM Bluerock Homes Trust Inc.

Bluerock Homes Trust Inc owns and operates a portfolio of institutional residential properties including single-family homes, build-to-rent communities, and other residential communities located in attractive markets with a focus on the knowledge-economy and high-quality of life growth markets of the Sunbelt and Western United States. The company's principal objective is to generate attractive risk-adjusted returns on investments where it believes it can drive growth in funds from operations and net asset value by acquiring residential units, developing residential communities, and through value-add renovations. The Company is an externally managed REIT managed and advised by Bluerock Homes Manager, LLC.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: